Phase III Study to Assess Creatine in Huntington's

ROCKVILLE, MD. — A phase III study of creatine for Huntington's disease is enrolling 650 HD patients, after phase II data showed promising results in 10 patients who have now been taking the supplement for nearly 4 years.